Background: Treatment of cytomegalovirus (CMV) diseases with protracted administration of
ganciclovir can promote the development of resistant CMV that is associated with a poor …

Plasma concentration of ganciclovir was studied prospectively in 15 AIDS patients treated
for acute cytomegalovirus (CMV) retinitis. Ganciclovir was administered at a mean dose of …

Cidofovir [CDV,(S)-(1)-(3-Hydroxy-2-phosphonylmethoxypropyl) cytosine, HPMPC]
sensitivities among HCMV clinical isolates from patients enrolled in the GS-101 clinical trial …

Cytomegaloviral retinitis was diagnosed in nine eyes of seven patients with acquired
immune deficiency syndrome (AIDS) on the basis of the characteristic ocular findings and a …

AIDS: In persons with AIDS (PWAs), cytomegalovirus (CMV) infection can cause a broad
spectrum of clinical manifestations. The most common clinical manifestations associated …

Ganciclovir and Foscarnet were compared in an open randomised trial as treatment and
secondary prophylaxis of cytomegalovirus (CMV) retinitis in patients with AIDS. Patients …

Fifty-four isolates of cytomegalovirus (CMV) from 25 immunocompromised patients with
CMV infections were examined in a plaque reduction assay to determine in vitro …

In a human immunodeficiency virus-infected subject, cytomegalovirus (CMV) isolated 9
months after the patient began oral ganciclovir prophylaxis was resistant to ganciclovir and …

Purpose: Children with the acquired immune deficiency syndrome (AIDS) and
cytomegalovirus (CMV) retinitis may not complain of symptoms despite the presence of …

An AIDS patient with cytomegalovirus (CMV) retinitis was treated with ganciclovir (10 mg/kg)
for four days followed by 5 mg/kg for 69 days. Clinically, CMV retinitis improved during …